Search | Engineering

订阅投稿

首页工程期刊工程焦点工程成就工程前沿关于我们 English

资源类型

期刊论文 4

年份

2023 1

2019 1

2018 1

2016 1

关键词

CAESAR竞赛；认证加密算法；分组密码；序列密码；哈希函数；安全性评估 1

人才发现 1

人才追踪 1

竞赛 1

网络空间安全 1

展开︾

检索范围：

排序：展示方式：

CAESAR竞赛认证加密算法设计分析与安全性评估进展 None

Fan ZHANG, Zi-yuan LIANG, Bo-lin YANG, Xin-jie ZHAO, Shi-ze GUO, Kui REN

《信息与电子工程前沿（英文）》 2018年第19卷第12期页码 1475-1499 doi: 10.1631/FITEE.1800576

摘要： CAESAR竞赛是2013年由美国国家标准与技术研究院（NIST）资助的认证加密算法征集竞赛，旨在征集综合性能和安全性优于AES-GCM的认证加密算法，能够同时实现完整性和机密性。竞赛分3个轮次，第3轮在2018年结束。本文首先介绍CAESAR竞赛候选算法的设计要求和筛选进展，然后从设计结构和加密模式两方面对最后一轮候选算法进行归类，之后综述了候选算法的综合性能与安全性分析进展，最后探讨了认证加密算法的设计和分析研究趋势

关键词： CAESAR竞赛；认证加密算法；分组密码；序列密码；哈希函数；安全性评估

HTML PDF 收藏

网络空间安全竞赛及人才管理

余翔湛,张宏莉,于海宁、田志宏、翟健宏、潘柱廷

《中国工程科学》 2016年第18卷第6期页码 49-52 doi: 10.15302/J-SSCAE-2016.06.010

摘要：本文调研了国内外网络空间安全竞赛的发展现状，分析了我国网络空间安全竞赛在网络空间安全人才发现和追踪方面存在的主要问题，提出了建立基于网络空间安全竞赛的网络空间安全人才发现和追踪的长效机制的政策建议。

关键词：网络空间安全竞赛人才发现人才追踪

HTML PDF 收藏

量子密码竞赛产生下一代标准算法

Chris Palmer

《工程（英文）》 2023年第21卷第2期页码 6-8 doi: 10.1016/j.eng.2022.12.002

HTML PDF 收藏

malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR

Ling Wang, Ying Wang, Jiong Hu, Yuqian Sun, He Huang, Jing Chen, Jianyong Li, Jun Ma, Juan Li, Yingmin Liang, Jianmin Wang, Yan Li, Kang Yu, Jianda Hu, Jie Jin, Chun Wang, Depei Wu, Yang Xiao, Xiaojun Huang

《医学前沿（英文）》 2019年第13卷第3期页码 365-377 doi: 10.1007/s11684-018-0641-0

摘要： Invasive fungal disease (IFD) is a major infectious complication in patients with hematological malignancies. In this study, we examined 4889 courses of chemotherapy in patients with hematological diseases to establish a training dataset ( =3500) by simple random sampling to develop a weighted risk score for proven or probable IFD through multivariate regression, which included the following variables: male patients, induction chemotherapy for newly diagnosed or relapsed disease, neutropenia, neutropenia longer than 10 days, hypoalbuminemia, central-venous catheter, and history of IFD. The patients were classified into three groups, which had low (0–10, ~1.2%), intermediate (11–15, 6.4%), and high risk (>15, 17.5%) of IFD. In the validation set ( =1389), the IFD incidences of the groups were ~1.4%, 5.0%, and 21.4%. In addition, we demonstrated that anti-fungal prophylaxis offered no benefits in low-risk patients, whereas benefits were documented in intermediate (2.1% vs. 6.6%, =0.007) and high-risk patients (8.4% vs. 23.3%, =0.007). To make the risk score applicable for clinical settings, a pre-chemo risk score that deleted all unpredictable factors before chemotherapy was established, and it confirmed that anti-fungal prophylaxis was beneficial in patients with intermediate and high risk of IFD. In conclusion, an objective, weighted risk score for IFD was developed, and it may be useful in guiding antifungal prophylaxis.

关键词： invasive fungal diseases hematological malignancies chemotherapy risk score prophylaxis